Defined periods with confirmed recovery between them showed largely reversible changes in the HAARLEM cohort. Continuous exposure is where the cumulative effects live: hematocrit that never normalises, years of low HDL, heart remodelling that tracks total exposure, and a hormonal axis that may not restart. A cruise at a true replacement level with clean bloodwork is closer to therapy; a cruise well above it is just a lower blast.
- HAARLEM: 100 amateur users followed through a cycle and a year after; almost all measured changes reversed after stopping.
- Long-term users with two or more years of cumulative exposure had reduced left ventricular function and more coronary plaque, scaling with exposure (Baggish et al., 2017).
- Former users years after stopping had lower testosterone and more hypogonadal symptoms than controls; current users showed severely reduced AMH and inhibin B (Rasmussen et al., 2016).
- Hematocrit peaks at 9–12 months of continuous exposure and stays there; with breaks it normalises.
- A cruise is only replacement if trough testosterone sits in the physiological range and hematocrit, lipids and blood pressure look like a healthy man's.
Two patterns, two datasets
Defined periods. Use for a set time, stop, recover fully, repeat or not. The HAARLEM cohort is this pattern: a cycle, then a year of follow-up. Almost everything measured went back to baseline.
Continuous. A higher phase (blast) alternating with a lower phase (cruise), never off. The long-term cohorts are this pattern: Baggish’s lifters with years of cumulative exposure, Rasmussen’s former users years after stopping. The findings there are the ones that do not reverse.
The difference is not the peak; it is time above physiological range with no reset.
What accumulates without a break
| Marker | With breaks | Continuous |
|---|---|---|
| Hematocrit | rises, normalises off | peaks at 9–12 months, stays |
| HDL / LDL | recover within weeks off | low HDL for years |
| Blood pressure | resets off | chronic load |
| Left ventricle, coronary plaque | reversible strain after a cycle (HAARLEM) | remodelling tracks cumulative exposure (Baggish) |
| Own testosterone | restarts, confirmed by blood | may not restart; former users low years later |
| Sperm, AMH, inhibin B | recover over months | suppressed the entire time |
What continuous use buys
No post-cycle window: no low-testosterone weeks, no mood crash, no loss of size between periods. That is a real benefit and the honest reason people choose it. The bill arrives on the other rows of the table, later and quietly.
If you stay on anyway
The cost is not fixed. It scales with how far above physiological the cruise sits and how much of the year is blast.
- Cruise at replacement, verified. Trough total testosterone in the normal range on a morning draw. If the trough is double the top of the range, it is not a cruise.
- Flat dosing. Frequent small injections remove the peaks that drive hematocrit and estrogen.
- No orals on the cruise. Keep the liver and HDL load to the blast, and keep the blast short.
- Three numbers every three months. Blood pressure daily at home; hematocrit and lipids every quarter; act on each. Thresholds.
- Bank sperm if children are possible. Fertility is suppressed the whole time, and recovery after years on is slow and uncertain.
- An echocardiogram once you pass a couple of years of exposure. Structural change is silent.
- Blasts short, cruises long. Cumulative exposure is what the cardiac data track; the ratio matters.
If you cycle
Make the break real: compound cleared, LH and FSH back, testosterone at your baseline, hematocrit and lipids normal, all on paper. Coming off well, keeping what you built. Two months off with no bloodwork is not a break, it is a pause with a crash attached.
Frequently asked questions
Is blast and cruise safer than cycling?
It avoids the post-cycle crash, which is real. It pays for that with no recovery of lipids, hematocrit or the hormonal axis, ever. The long-term cardiac and fertility data come from people with years of continuous exposure. Cycling with real breaks is the pattern the reversibility data come from.
What counts as a real break?
Compound cleared, LH and FSH back, testosterone back at your own baseline, lipids and hematocrit normalised, confirmed by blood. Two months off with nothing tested is a pause, not a break.
If I stay on, what reduces the cost?
Cruise at a genuine replacement level, verified by trough testosterone; flat dosing to remove peaks; hematocrit, lipids and blood pressure every three months with action on each; no orals on the cruise; blasts short and infrequent; sperm banked if children are possible.
Can the axis recover after years on?
Sometimes, slowly, and not always. Rasmussen's former users were still low years later. The longer the continuous exposure, the less likely a full spontaneous restart, which is why long-term users often end up on prescribed replacement.
Does cycling lose the gains?
Some size, in the low-hormone window. Nuclei stay and regaining is fast. The trade is a few kilos of temporary size against a hormonal system and blood profile that reset. Keeping gains through the window is mostly training and food.
Sources
- Smit DL et al. Health effects of androgen abuse: a review of the HAARLEM study. 2022.
- Baggish AL et al. Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation, 2017.
- Rasmussen JJ et al. Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation. PLoS One, 2016.
- Saad F et al. Onset of effects of testosterone treatment and time span until maximum effects are achieved. European Journal of Endocrinology, 2011.